Trademark applications and grants for Jina Pharmaceuticals Inc. Jina Pharmaceuticals Inc has 1 trademark applications. The latest application filed is for "NANOAQUALIP"
Patent Application | Date |
---|---|
ENDOXIFEN FOR THE TREATMENT OF BIPOLAR I DISORDER 20210322342 - 17/226703 AHMAD; Ateeq ;   et al. | 2021-10-21 |
ENDOXIFEN FOR THE TREATMENT OF BIPOLAR I DISORDER 20210315845 - 17/226671 AHMAD; Ateeq ;   et al. | 2021-10-14 |
ENDOXIFEN FOR THE TREATMENT OF BIPOLAR I DISORDER 20210315844 - 17/226651 AHMAD; Ateeq ;   et al. | 2021-10-14 |
ENDOXIFEN FOR THE TREATMENT OF BIPOLAR I DISORDER 20210315843 - 17/226628 AHMAD; Ateeq ;   et al. | 2021-10-14 |
ENDOXIFEN METHODS AND COMPOSITIONS FOR INHIBITION OF PROTEIN KINASE C 20210177752 - 17/023208 Ahmad; Ateeq ;   et al. | 2021-06-17 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
![]() "NANOAQUALIP" 4368892 85074885 |
NANOAQUALIP 2010-06-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.